JACQUELINE ANN COX MD NPI 1538153564

NPI Information

  • NPI: 1538153564
  • Provider Name: JACQUELINE ANN COX, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1640 COWLES ST
    SUITE 1
    FAIRBANKS, AK
    ZIP 99701
  • Phone: (907) 452-4768

Map and Directions

Get Directions

NPI Details

Jacqueline Ann Cox, MD is a hematology and oncology internal medicine in Fairbanks, AK with 31 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Jacqueline Ann Cox, MD NPI is 1538153564. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: TEMPLE UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1995

The provider's business location address is:

1640 COWLES ST
SUITE 1
FAIRBANKS, AK
ZIP 99701-992
Phone: (907) 452-4768
Fax: (907) 452-1009

The NPI 1538153564 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, lorazepam, 2 mg (HCPCS:J2060)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
  • Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)

The enumeration date for this NPI number is 9/6/2005 and was last updated on 10/13/2009.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology5565ALASKAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1K160116MEDICARE ID-TYPE UNSPECIFIEDALASKA
2G80242MEDICARE UPIN
3K162480MEDICARE PINALASKA
4MD 6153MEDICAIDALASKA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.